What is the current Price Target for the Catalyst Biosciences, Inc. stock?

The average Catalyst Biosciences, Inc. target price is $45.00. This is 210.99% higher than the current stock price. 1 Analyst has issued a Catalyst Biosciences, Inc. price target 2025.

How high will the Catalyst Biosciences, Inc. stock rise?

No reliable answer can be given as to how high the Catalyst Biosciences, Inc. stock will rise. The performance of stocks, including the Catalyst Biosciences, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Catalyst Biosciences, Inc. stock today?

The performance of Catalyst Biosciences, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Catalyst Biosciences, Inc. stock fall?

The decline in Catalyst Biosciences, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Catalyst Biosciences, Inc. Forecast, price target & analysts

$14.47

1.19%

Nasdaq, Fri, Nov 01 2024

ISIN

US14888D2080

Symbol

CBIO

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts Strategies

Catalyst Biosciences, Inc. Target price 2024 - Analyst rating & recommendation

Catalyst Biosciences, Inc. Classifications & Recommendation:

Buy

50%

Hold

50%

Catalyst Biosciences, Inc. Price Target

Target Price	$45.00
Price	$14.47
Potential	210.99% register free of charge
Number of Estimates	1

	1 Analyst has issued a Catalyst Biosciences, Inc. price target 2025. The average Catalyst Biosciences, Inc. target price is $45.00. This is 210.99% register free of charge higher than the current stock price.
	A rating was issued by 4 analysts: 2 Analysts recommend Catalyst Biosciences, Inc. to buy, 2 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Catalyst Biosciences, Inc. stock has an average upside potential 2025 of 210.99% register free of charge . Most analysts recommend the Catalyst Biosciences, Inc. stock at Buy or hold.

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '23	2024 Estimates
Earnings Per Share $	-1.41	0.45
	64.03%	131.91%
P/E		31.73
EV/Sales		9.59

1 Analysts have issued a Catalyst Biosciences, Inc. forecast for earnings per share. The average Catalyst Biosciences, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2023	$-1.41	64.03%
2024	$0.45 131.91% Unlock
2025	$0.63 40.00% Unlock
2026	$0.95 50.79% Unlock

Current	-0.82	11.83%
2024	31.73 3,969.51% Unlock
2025	22.57 28.87% Unlock
2026	15.01 33.50% Unlock

Catalyst Biosciences, Inc....

Discover more stocks with a high price target

Valneva 206.16%

CureVac N.V. 152.80%

Plug Power Inc. 89.59%

Bavarian Nordic 46.30%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now